Fig. 2From: Comparison of the effect of rhodium citrate-associated iron oxide nanoparticles on metastatic and non-metastatic breast cancer cellsAnalysis of migration capacity of MDA-MB-231 cells after treatment with 100 mM rhodium citrate associated with maghemite nanoparticles (MRC). Micrographs of migrant untreated (control) or treated MDA-MB-231 cells. The graph represents the cell counts. (**) p ≤ 0.01Back to article page